There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Globus Medical (GMED – Research Report) and ...

Taking full advantage of the stock market and investing with confidence are common goals for new and old investors, and Zacks Premium offers many different ways to do both. Featuring daily updates of ...

Globus Medical Inc. (NYSE:GMED), a medical device company with a market capitalization of $12 billion and an "GREAT" financial health rating according to InvestingPro, reaffirmed its commitment to ...

Globus Medical (GMED) has agreed to buy Nevro (NVRO) through an all-cash deal valued at around $250M. Read more here.

In a report released today, David Saxon from Needham maintained a Hold rating on Globus Medical (GMED – Research Report). The company’s shares ...

Globus Medical (NYSE:GMED) announced today that it agreed to acquire chronic pain treatment developer Nevro (NYSE:NVRO).

The Value Style Score utilizes ratios like P/E, PEG, Price/Sales, Price/Cash Flow ... Momentum investors should take note of this Medical stock. GMED has a Momentum Style Score of A, and shares ...

They currently have a buy rating on the medical device company’s stock. Several other research analysts also recently commented on GMED. Roth Mkm lifted their target price on shares of Globus ...

Momentum trading is all about taking advantage of upward or downward trends in a stock's price or earnings outlook ... Audubon, PA-based Globus Medical, Inc. is a medical device company that ...